Stanley Iyadurai
Technik-/Wissenschafts-/F&E-Leiter bei CATALYST PHARMACEUTICALS, INC.
Aktive Positionen von Stanley Iyadurai
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 20.08.2018 | - |
Karriereverlauf von Stanley Iyadurai
Ehemalige bekannte Positionen von Stanley Iyadurai
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | 01.07.2017 | 01.07.2018 |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - | - |
Ausbildung von Stanley Iyadurai
| University of Minnesota | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
- Börse
- Insiders
- Stanley Iyadurai
- Erfahrung
